2.08
price up icon0.48%   0.01
pre-market  プレマーケット:  2.07   -0.01   -0.48%
loading

Compass Therapeutics Inc (CMPX) 最新ニュース

pulisher
Jul 27, 2026

Compass Therapeutics Inc. (CMPX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Compass Therapeutics Inc. (CMPX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Compass Therapeutics Inc. (CMPX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026
pulisher
Jul 26, 2026

TradingKey - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

CMPX|Compass Therapeutics Inc.|Price:2.092|Chg%:+0.022 - TradingKey

Jul 26, 2026
pulisher
Jul 24, 2026

Compass Therapeutics, Inc. Revenue Breakdown – NASDAQ:CMPX - TradingView

Jul 24, 2026
pulisher
Jul 24, 2026

Compass Therapeutics Inc. (CMPX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 24, 2026
pulisher
Jul 18, 2026

Enterprise value to EBIT forward of Compass Therapeutics, Inc. – NASDAQ:CMPX - TradingView

Jul 18, 2026
pulisher
Jul 18, 2026

Compass Therapeutics (CMPX) Jefferies Global Healthcare Conference 2026 Summary - Quartr

Jul 18, 2026
pulisher
Jul 17, 2026

Compass Therapeutics to present Phase 2/3 tovec... - Pluang

Jul 17, 2026
pulisher
Jul 17, 2026

Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026 - The Manila Times

Jul 17, 2026
pulisher
Jul 17, 2026

Compass Therapeutics’ COMPANION-002 Biliary Tract Cancer Study Accepted for Oral Presentation at ESMO 2026 - Quiver Quantitative

Jul 17, 2026
pulisher
Jul 17, 2026

Compass Therapeutics Inc. (CMPX) Institutional Confidence - TradingKey

Jul 17, 2026
pulisher
Jul 17, 2026

CMPX Stock Has Retail Buzzing Ahead Of High-Stakes Cancer Drug Trial Update - Stocktwits

Jul 17, 2026
pulisher
Jul 15, 2026

Compass Therapeutics: A 50% Price Cut Hiding A Regulatory Mispricing Opportunity - Seeking Alpha

Jul 15, 2026
pulisher
Jul 13, 2026

Compass Therapeutics Q1 2026 Earnings: Narrower-than-Expected Loss as Clinical Pipeline AdvancesInvestor Earnings Call - DonanımHaber

Jul 13, 2026
pulisher
Jul 13, 2026

Compass Therapeutics Inc. (CMPX) Q1 2026 Earnings: Narrower-Than-Expected Loss Reinforces Clinical-Stage Focus - dars.gov.et

Jul 13, 2026
pulisher
Jul 12, 2026

Compass Therapeutics Inc. (CMPX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 12, 2026
pulisher
Jul 10, 2026

Compass Therapeutics Inc. (CMPX) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jul 10, 2026
pulisher
Jul 09, 2026

Compass Therapeutics Inc. (CMPX) Q1 2026 Earnings: Narrower-Than-Expected Loss Driven by Disciplined SpendingHigh Estimate Range - dars.gov.et

Jul 09, 2026
pulisher
Jul 08, 2026

Compass Therapeutics (CMPX) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr

Jul 08, 2026
pulisher
Jul 04, 2026

If You Invested $1,000 in Compass Therapeutics Inc (CMPX) - Stock Titan

Jul 04, 2026
pulisher
Jul 03, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review

Jul 03, 2026
pulisher
Jul 03, 2026

Here’s Why Citizens Maintains a Buy on Compass Therapeutics (CMPX) - Insider Monkey

Jul 03, 2026
pulisher
Jul 02, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Compass Thera - The National Law Review

Jul 02, 2026
pulisher
Jul 01, 2026

Compass Showcases Promising Tovecimig Data, Eyes Commercialization - TipRanks

Jul 01, 2026
pulisher
Jul 01, 2026

Compass updates corporate presentation, reports positive Phase 2/3 COMPANION-002 BTC data and plans BLA engagement - TradingView

Jul 01, 2026
pulisher
Jul 01, 2026

Compass Therapeutics (NASDAQ: CMPX) targets BLA after biliary tract cancer trial success - Stock Titan

Jul 01, 2026
pulisher
Jul 01, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Compass Therapeutic - The National Law Review

Jul 01, 2026
pulisher
Jun 30, 2026

A Clinical-Stage Cancer Company Is Putting AI to Work Designing Its Next Generation of Tumor-Targeting Drugs - Sahm

Jun 30, 2026
pulisher
Jun 29, 2026

Enterprise value to revenue forward of Compass Therapeutics, Inc. – NASDAQ:CMPX - TradingView

Jun 29, 2026
pulisher
Jun 29, 2026

Price to sales forward of Compass Therapeutics, Inc. – NASDAQ:CMPX - TradingView

Jun 29, 2026
pulisher
Jun 29, 2026

Price to earnings forward of Compass Therapeutics, Inc. – NASDAQ:CMPX - TradingView

Jun 29, 2026
pulisher
Jun 29, 2026

$Compass Therapeutics (CMPX.US)$ - Moomoo

Jun 29, 2026
pulisher
Jun 29, 2026

Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 3000E Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 28, 2026

Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 3000 Growth Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 2000 Growth Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 2500 Growth Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 26, 2026

Compass Therapeutics (CMPX) Stock Forecast & Analyst Ratings - Moomoo

Jun 26, 2026
pulisher
Jun 25, 2026

Compass Therapeutics, Inc. Actuals & Estimates (NASDAQ:CMPX) - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

CMPX Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Compass Therapeutics (CMPX) News Flow - Moomoo

Jun 25, 2026
pulisher
Jun 24, 2026

Compass Therapeutics Adopts Second Amended and Restated Bylaws - The Globe and Mail

Jun 24, 2026
pulisher
Jun 20, 2026

Compass Therapeutics Q1 2026 Earnings: Narrow EPS Beat Amid No Revenue; Stock Declines SlightlyAdjusted Earnings Analysis - dars.gov.et

Jun 20, 2026
pulisher
Jun 17, 2026

Compass Therapeutics Inc. (CMPX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

How Compass Therapeutics (CMPX) Is Moving Tovecimig Toward a Potential Biliary Tract Cancer Filing - Insider Monkey

Jun 17, 2026
pulisher
Jun 16, 2026

5 Small Cap Stocks with Potential to Rise 1000 Percent - Insider Monkey

Jun 16, 2026
$91.09
price up icon 1.97%
$118.87
price up icon 1.02%
$34.72
price down icon 0.83%
$58.73
price down icon 0.17%
ONC ONC
$325.90
price up icon 0.00%
$278.40
price up icon 2.44%
大文字化:     |  ボリューム (24 時間):